Concepedia

Publication | Closed Access

The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases

DOI

22

Citations

17

References

2007

Year

Tanja Langsenlehner, Uwe Langsenlehner, Wilfried Renner, Karin S. Kapp, Peter Krippl, Günter Hofmann, H.-E. Clar, Karl Pummer, Ramona Mayer
The Prostate

Abstract

We conclude that the TNFRSF10A Glu228Ala polymorphism may be a novel independent risk factor for prostate cancer metastases after radiation therapy.

References

YearCitations

Page 1